CL2011000717A1 - Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection. - Google Patents

Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection.

Info

Publication number
CL2011000717A1
CL2011000717A1 CL2011000717A CL2011000717A CL2011000717A1 CL 2011000717 A1 CL2011000717 A1 CL 2011000717A1 CL 2011000717 A CL2011000717 A CL 2011000717A CL 2011000717 A CL2011000717 A CL 2011000717A CL 2011000717 A1 CL2011000717 A1 CL 2011000717A1
Authority
CL
Chile
Prior art keywords
hepatitis
virus
treatment
vhc
solvate
Prior art date
Application number
CL2011000717A
Other languages
Spanish (es)
Inventor
Zha
Dhanapalan Nagarathnam
Michael Joseph Sofia
Wonsuk Chag
Devan Naduthambi
Ganapati Reddy Pomulapati
Bruce S Ross
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47146037&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000717(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Publication of CL2011000717A1 publication Critical patent/CL2011000717A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuesto cristalino derivado de fosforamidato de nucleósido de purina; composición farmacéutica; método de tratamiento del virus de la hepatitis C (HVC); proceso para prepararlo; y método para determinar cristalinidad del compuesto.Crystalline compound derived from purine nucleoside phosphoramidate; pharmaceutical composition; method of treatment of hepatitis C virus (HVC); process to prepare it; and method to determine crystallinity of the compound.

CL2011000717A 2010-03-31 2011-03-31 Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection. CL2011000717A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31954810P 2010-03-31 2010-03-31
US33594010P 2010-06-17 2010-06-17

Publications (1)

Publication Number Publication Date
CL2011000717A1 true CL2011000717A1 (en) 2012-04-09

Family

ID=47146037

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000717A CL2011000717A1 (en) 2010-03-31 2011-03-31 Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection.

Country Status (2)

Country Link
AR (1) AR081813A1 (en)
CL (1) CL2011000717A1 (en)

Also Published As

Publication number Publication date
AR081813A1 (en) 2012-10-24

Similar Documents

Publication Publication Date Title
PH12015502799A1 (en) Substituted nucleosides, nucleotides and analogs thereof
PH12020551055A1 (en) Methods for treating filoviridae virus infections
EA201590943A1 (en) SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND THEIR ANALOGUES
PH12018500931A1 (en) Hcv polymerase inhibitors
PH12015502273A1 (en) Substituted nucleosides, nucleotides and analogs thereof
UA116083C2 (en) Purine derivatives for the treatment of viral infections
PH12016502563A1 (en) Substituted nucleosides, nucleotides and analogs thereof
PH12014502094A1 (en) Substituted nucleosides, nucleotides and analogs thereof
PH12016500660A1 (en) Substituted nucleosides, nucleotides and analogs thereof
BR112017013028A2 (en) nucleosides, nucleotides and analogs thereof substituted
UY33620A (en) NUCLEOSID AND NUCLEOTIDE AZIDO ANALOGS
PH12017501598A1 (en) �-D-2`-DEOXY-2`a-FLUORO-2`-�-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
CL2011000717A1 (en) Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection.